Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medical Device Start-Ups in Germany

This article was originally published in Start Up

Executive Summary

Despite the important role that French, German, and other European physicians play in developing and trialing new technology, and the equally important role that EU regulators play in offering a quick path to commercialization, the number of native European medical device companies is surprisingly small. There are hints that the bleak devicie picture might be brightening, however.

You may also be interested in...



invendo medical GMBH

invendo medical has crystallized its mission around solving not just the single issue of sedationless colonoscopy, which is regarded by some as the solution to getting more patients into the endoscopy suite for colorectal cancer screening, but all three of what the company characterizes as the major drawbacks of colonoscopy: 1) patient discomfort (triggering the costs and complications of sedation); 2) the ease-of-use issue, or rather, the challenging learning curve of conventional endoscopes; and 3) the reusability that leads to cumbersome cleaning routines and residual infection risk. Invendo has developed a non-push scope that drives itself under the operator's control.

The Lonely World of European Device Start-Ups

Because of a conservative clinical culture and a skittish venture community, medical-device company creation has lagged in Europe. The reasons for the lack of device company creation are several: a physician community that is not only not entrepreneurial, but often averse to capitalizing on commercial opportunities; a venture capital community unfamiliar with devices; and a lack of

Berlin Heart AG

With both paracorporeal and implantable ventricular assist devices in development for heart failure, Berlin Heart's goal is to enter the treatment continuum at an earlier stage and enable patients to avoid transplants, and perhaps even enable heart recovery.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel